Skip to content

Comparing Nutritional Status of In-centre Nocturnal Hemodialysis Patients to Conventional Hemodialysis Patients

Comparing Nutritional Status of In-centre Nocturnal Hemodialysis Patients to Conventional Hemodialysis Patients: A Prospective Cohort Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02887391
Enrollment
20
Registered
2016-09-02
Start date
2016-01-31
Completion date
2017-06-30
Last updated
2016-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Failure on Dialysis

Keywords

hemodialysis, nutritional status

Brief summary

Although hemodialysis is life-saving, unfortunately, people on dialysis often have declining health, quality of life as well as poor nutritional status. Hemodialysis patients must follow a very restrictive diet, and many patients do not eat well and usually report poor appetites. A new approach to dialysis is being used in some hospitals in Alberta and elsewhere, called in-centre nocturnal hemodialysis. This in-centre nocturnal dialysis allows people to receive their dialysis at a hospital or clinic while they sleep. Since this in-centre nocturnal dialysis gives people 8-hour hemodialysis treatment 3 times per week (24 hours of dialysis per week) the patients have better removal of the waste products from their bodies than conventional hemodialysis (an average of 12 hours per week). Also of importance, when using in-centre nocturnal dialysis, people will have more time during the day to work, spend with family, as well as have time to shop for food, to cook and even to eat, which in turn will likely result in improvement in the quality of their lives. This study will follow 10 patients on conventional dialysis and 10 patients on in-centre nocturnal dialysis for 6 months and compare their food intake, muscle mass, weight, body mass index (BMI) and nutrition-related lab tests. The purpose of this study is to determine whether there is an improvement in the nutritional status of the in-centre nocturnal hemodialysis patients compared to the nutritional status of conventional hemodialysis patients.

Interventions

No intervention - observational study

Sponsors

University of Calgary
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>18 years of age * referred to the in-centre nocturnal hemodialysis program * medically stable * undergo hemodialysis three to four times per week for a minimum of three hours per week * able to provide written, informed consent

Exclusion criteria

* younger than 18 years old * have a current diagnosis with palliative status (e.g. cancer) or have active disease * have had a prolonged hospitalization (\>3 weeks) within the previous 3 months

Design outcomes

Primary

MeasureTime frameDescription
Malnutrition Inflammation Score (MIS)Baseline & 6 monthsA survey/tool that uses both subjective global assessment and objective laboratory measures to evaluate nutritional status. Change from baseline MIS at 6 months will be measured in both groups.

Secondary

MeasureTime frameDescription
Dietary IntakeBaseline & 6 months3 day food records will be administered to document changes in dietary intake. Will be measured at baseline and change after 6 months in both groups.
AppetiteBaseline & 6 monthsSimplified Nutritional Appetite Questionnaire (SNAQ) will be administered to document changes in appetite. Will be measured at baseline and change after 6 months in both groups.
Interdialytic Weight GainBaseline & 6 monthsMeasurement of fluid weight gain between dialysis sessions; Will be measured in both groups at baseline and after 6 months.
Body Mass Index (BMI)Baseline & 6 monthsBody Mass Index (BMI) will be used to assess change in weight over time. Will be measured in both groups at baseline and after 6 months.
Triceps Skinfold ThicknessBaseline & 6 monthsTriceps skinfold thickness will be used to assess changes in muscle and fat mass over time. Will be measured in both groups at baseline and after 6 months.
Mid Arm (Muscle) CircumferenceBaseline & 6 monthsMid arm (muscle) circumference will be used to assess changes in muscle and fat mass over time. Will be measured in both groups at baseline and after 6 months.
Quality of LifeBaseline & 6 monthsKDQOL (SF-36) will be used to measure the quality of life in both groups at baseline and change after 6 months.
Bio-electrical ImpedanceBaseline & 6 monthsThis is completed as one measurement to assess body composition (fat, fluid, muscle). Will be measured at baseline and after 6 months in both groups.
Serum AlbuminBaseline & 6 monthsSerum albumin will be measured as part of hemodialysis standard of care. Change in baseline serum albumin will be evaluated at 6 months.
C-reactive protein (CRP)Baseline & 6 monthsC-reactive protein will be measured as part of hemodialysis standard of care. Change in baseline CRP will be evaluated at 6 months.
Total iron binding capacity (TIBC)Baseline & 6 monthsTotal iron binding capacity (TIBC) will be measured as part of hemodialysis standard of care. Change in baseline TIBC will be evaluated at 6 months.
Phosphate BindersBaseline & 6 monthsChanges in use and number/dose of phosphate binders will be measured at baseline and after 6 months in both groups.
Handgrip StrengthBaseline & 6 monthsHandgrip strength will be used to assess changes in muscle strength over time. Will be measured in both groups at baseline and after 6 months.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026